ASIA-PACIFIC VETERINARY VACCINES MARKET 2019-2028

Lifesciences | Healthcare & Wellness

ASIA-PACIFIC VETERINARY VACCINES MARKET 2019-2028

Market by Vaccine Type, Technology, Disease Type, and Country | Forecast 2019-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

The Asia-Pacific veterinary vaccines market is evaluated to display growth in revenue at 6.02% of CAGR during the forecast period 2019-2028.


Report scope can be customized per your requirements. Request For Customization

The countries studied in this market include:

•        India

•        China

•        Japan

•        Australia & New Zealand

•        South Korea

•        ASEAN countries

•        Rest of APAC

In Asia-Pacific, the developing nations have witnessed significant progress in the pet care industry. For instance, in India, there is a gradual growth in this industry, owing to the rise in the awareness regarding pet health and care products. Moreover, there is a growth in the adoption of pets every year, which augments the production of vaccines to suit their healthcare needs. This further facilitates the development of vaccine technology, fostering the evolution of the veterinary vaccines market in India.  

In Japan, the foot-and-mouth disease has affected several livestock animals such as cattle, pigs, and water buffaloes. Also, there is a rise in zoonosis occurrence in the country, leading to the slaughtering of animals affected by such conditions. Further, many animals and livestock products are imported into the country, which increases the possibility of new zoonosis to spread in Japan. This surge in the incidence of animal diseases requires the frequent use of vaccines to manage such conditions. Therefore, the growing prevalence of livestock and zoonotic diseases indicate a positive growth opportunity for the Japanese veterinary vaccines market. 

Hester Biosciences Ltd is involved in thriving towards attaining better health among all animal species, along with monitoring and preventing animal diseases. The company manufactures and trades poultry vaccines and animal health products. It has its operations in different segments, such as live vaccines, inactivated vaccines, health products, and disinfectants & sanitizers. The live and inactivated vaccines assist in the immunization process against veterinary diseases of economic importance. The company is headquartered in Ahmedabad, India.     

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    ASIA-PACIFIC VETERINARY VACCINES MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTER’S FIVE FORCES MODEL

2.2.1.   THREAT OF NEW ENTRANTS

2.2.2.   THREAT OF SUBSTITUTE PRODUCTS

2.2.3.   BARGAINING POWER OF BUYERS

2.2.4.   BARGAINING POWER OF SUPPLIERS

2.2.5.   THREAT OF COMPETITIVE RIVALRY

2.3. IMPACT OF COVID-19 ON VETERINARY VACCINES MARKET

2.4. INDUSTRY COMPONENTS

2.5. MARKET ATTRACTIVENESS INDEX

2.6. VENDOR SCORECARD

2.7. MARKET DRIVERS

2.7.1.   GROWTH IN PREVALENCE OF ZOONOTIC DISEASES

2.7.2.   RISE IN LIVESTOCK DISEASES

2.8. MARKET RESTRAINTS

2.8.1.   ADVERSE EFFECTS OF POST-VACCINATION

2.8.2.   SHORTAGE OF SKILLED FARMWORKERS

2.9. MARKET OPPORTUNITIES

2.9.1.   INCREASE IN NUMBER OF INITIATIVES BY GOVERNMENT AGENCIES

2.9.2.   GROWTH IN MOMENTUM OF PET OWNERSHIP

2.10.  MARKET CHALLENGE

2.10.1.  HIGH COSTS OF VACCINATIONS

3.    ASIA-PACIFIC VETERINARY VACCINES MARKET OUTLOOK - BY VACCINE TYPE

3.1. LIVESTOCK VACCINE

3.1.1.   PORCINE VACCINE

3.1.2.   BOVINE VACCINE

3.1.3.   POULTRY VACCINE

3.1.4.   AQUACULTURE VACCINE

3.1.5.   OTHER LIVESTOCK VACCINE

3.2. COMPANION VACCINE

3.2.1.   CANINE VACCINE

3.2.2.   FELINE VACCINE

3.2.3.   EQUINE VACCINE

4.    ASIA-PACIFIC VETERINARY VACCINES MARKET OUTLOOK - BY TECHNOLOGY

4.1. LIVE ATTENUATED VACCINE

4.2. INACTIVATED VACCINE

4.3. RECOMBINANT VACCINE

4.4. TOXOID VACCINE

4.5. OTHER TECHNOLOGY

5.    ASIA-PACIFIC VETERINARY VACCINES MARKET OUTLOOK - BY DISEASE TYPE

5.1. CANINE DISEASE

5.2. PORCINE DISEASE

5.3. BOVINE DISEASE

5.4. POULTRY DISEASE

5.5. AQUACULTURE DISEASE

5.6. OTHER DISEASE TYPE

6.    ASIA-PACIFIC VETERINARY VACCINES MARKET - REGIONAL OUTLOOK

6.1. COUNTRY ANALYSIS

6.1.1.   CHINA

6.1.2.   JAPAN

6.1.3.   INDIA

6.1.4.   AUSTRALIA & NEW ZEALAND

6.1.5.   SOUTH KOREA

6.1.6.   ASEAN COUNTRIES

6.1.7.   REST OF ASIA-PACIFIC

7.    COMPANY PROFILES

7.1. BOEHRINGER INGELHEIM ANIMAL HEALTH GMBH

7.2. CEVA SANTE ANIMALE

7.3. HYGIEIA BIOLOGICAL LABORATORIES

7.4. ANICON LABOR GMBH

7.5. PHIBRO ANIMAL HEALTH CORP

7.6. ROMVAC COMPANY SA

7.7. ELANCO (ELI LILLY AND COMPANY)

7.8. VAXXINOVA GMBH-GERMANY

7.9. ZOETIS

7.10.   HESTER BIOSCIENCES LIMITED

7.11.    HIPRA

7.12.   VIRBAC SA

7.13.     MERCK & CO

7.14.      NEOGEN CORPORATION

8.    RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.1.1.   OBJECTIVES OF STUDY

8.1.2.   SCOPE OF STUDY

8.2. SOURCES OF DATA

8.2.1.   PRIMARY DATA SOURCES

8.2.2.   SECONDARY DATA SOURCES

8.3. RESEARCH METHODOLOGY

8.3.1.   EVALUATION OF PROPOSED MARKET

8.3.2.   IDENTIFICATION OF DATA SOURCES

8.3.3.   ASSESSMENT OF MARKET DETERMINANTS

8.3.4.   DATA COLLECTION

8.3.5.   DATA VALIDATION & ANALYSIS

List of table

TABLE 1: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)

TABLE 2: MARKET SNAPSHOT - VETERINARY VACCINE

TABLE 3: VENDOR SCORECARD

TABLE 4: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY VACCINE TYPE, 2019-2028 (IN $ MILLION)

TABLE 5:ASIA-PACIFIC LIVESTOCK VACCINE MARKET, BY TYPE, 2019-2028 (IN $ MILLION)  

TABLE 6: COMMERCIALLY AVAILABLE PORCINE VACCINES

TABLE 7: COMMERCIALLY AVAILABLE POULTRY VACCINES

TABLE 8:ASIA-PACIFIC COMPANION VACCINE MARKET, BY TYPE, 2019-2028 (IN $ MILLION)   

TABLE 9: COMMERCIALLY AVAILABLE CANINE VACCINES

TABLE 10: COMMERCIALLY AVAILABLE FELINE VACCINES

TABLE 11: COMMERCIALLY AVAILABLE EQUINE VACCINES

TABLE 12: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2019-2028 (IN $ MILLION)

TABLE 13: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY DISEASE TYPE, 2019-2028 (IN $ MILLION)

List of Figures

FIGURE 1: ASIA-PACIFIC VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 2: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY LIVESTOCK VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 3: ASIA-PACIFIC LIVESTOCK VACCINE MARKET, BY PORCINE VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 4: ASIA-PACIFIC LIVESTOCK VACCINE MARKET, BY BOVINE VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 5: ASIA-PACIFIC LIVESTOCK VACCINE MARKET, BY POULTRY VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 6: ASIA-PACIFIC LIVESTOCK VACCINE MARKET, BY AQUACULTURE VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 7: ASIA-PACIFIC LIVESTOCK VACCINE MARKET, BY OTHER LIVESTOCK VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 8: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY COMPANION VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 9: ASIA-PACIFIC COMPANION VACCINE MARKET, BY CANINE VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 10: ASIA-PACIFIC COMPANION VACCINE MARKET, BY FELINE VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 11: ASIA-PACIFIC COMPANION VACCINE MARKET, BY EQUINE VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 12: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY LIVE ATTENUATED VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 13: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY INACTIVATED VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 14: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY RECOMBINANT VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 15: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY TOXOID VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 16: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY OTHER TECHNOLOGY, 2019-2028 (IN $ MILLION)

FIGURE 17: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY CANINE DISEASE, 2019-2028 (IN $ MILLION)

FIGURE 18: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY PORCINE DISEASE, 2019-2028 (IN $ MILLION)

FIGURE 19: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY BOVINE DISEASE, 2019-2028 (IN $ MILLION)

FIGURE 20: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY POULTRY DISEASE, 2019-2028 (IN $ MILLION)

FIGURE 21: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY AQUACULTURE DISEASE, 2019-2028 (IN $ MILLION)

FIGURE 22: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY OTHER DISEASE TYPE, 2019-2028 (IN $ MILLION)

FIGURE 23: CHINA VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 24: JAPAN VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 25: INDIA VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 26: AUSTRALIA & NEW ZEALAND VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 27: SOUTH KOREA VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 28: ASEAN COUNTRIES VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 29: REST OF ASIA-PACIFIC VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)       

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;